PS.

Herpes zoster, inactivated vaccine (2027)

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencycontractFind a Tender ↗Ref ocds-h6vhtk-066916Procurement Act 2023pending

Estimated value

—

Awarded value

—

Suppliers

1

Lots

1

1 awarded

Published

13 Mar 2026

Description

The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.

Scope

Reference
CM/PHV/27/C384964
Commercial tool
Standalone contract

Submission & procedure

Procedure
Direct award

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

31 Mar 2027

Contract end

31 Mar 2029

Awarded to
GU
GlaxoSmithKline UK Limited